1478877

ORLISTAT RELATED COMPOUND D SOLUTION

United States Pharmacopeia (USP) Reference Standard

• 別名: N-Formyl-L-leucine (3S,4R,6S)-3-hexyl-2-oxo-6-undecyltetrahydro-2H-pyran-4-yl ester
• 実験式（ヒル表記法）: C₂₉H₅₃NO₅
• CAS番号: 130793-27-0
• 分子量: 495.73
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• 認証: USP
• APIファミリー: orlistat
• メーカー／製品名: USP
• アプリケーション: pharmaceutical
• フォーマット: neat
• InChI: 1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24-21-27(25(28(32)34-24)19-17-10-8-6-2)35-29(33)26(30-22-31)20-23(3)4/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27+/m0/s1
• InChI Key: IYWNIYFHQZQPBP-YIPNQBBMSA-N

詳細

詳細

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

アプリケーション

Orlistat Related Compound Solution USP Reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Orlistat
• Orlistat Capsules

アナリシスノート

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS02,GHS07
• シグナルワード: Danger
• 危険有害性情報: H225,H302 + H312 + H332,H319
• 注意書き: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P305 + P351 + P338
• 危険有害性の分類: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2
• 保管分類コード: 3 - Flammable liquids
• WGK: WGK 2
• 引火点(°F): 35.6 °F - closed cup
• 引火点(℃): 2.0 °C - closed cup